moderna

We've almost all been hit with a horror stomach bug. At best, it's a 24-hour nightmare, and at worst it's deadly. But huge strides are being taken towards the first Salmonella and norovirus vaccines, which could make severe illness a distant memory.

Moderna has announced results of a Phase 2b trial of its mRNA treatment for skin cancer. When paired with immunotherapy, the treatment significantly reduced risks of recurrence, metastasis and death, paving the way for trials against other cancers.

Sure, parts of the world are understandably feeling a bit of vaccine fatigue. But we're not too far off the first combination mRNA jab, which aims to offer seasonal protection against COVID-19 and influenza. Moderna hopes to be first out of the blocks.